BioCurex, Inc.(fka BOCX)

[Kag]

Mata Hari, Yes, you are correct, back in 2006 I was optimistic about BioCurex's prospects right up to the time when I learned that a RECAF test does not give the location of the cancer. The next fly in the ointment for me was a May 16, 2006 BioCurex press release that stated:

“But, if we did sequential blood tests on each person and assuming their RECAF value is rather constant over time, then a small change in the level of circulating RECAF would detect cancer at the earliest stages. We do not know yet if the normal RECAF concentration is constant enough to make this personalization possible.”

So, Mata Hari, early on, when I thought BioCurex was a possible good investment, I posted that. Later, around mid 2006, I began posting my concerns. So far, for me, those concerns are still valid. kag